Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations
Open Access
- 18 June 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (8), 2819-2829
- https://doi.org/10.1210/clinem/dgaa360
Abstract
Context While individuals with diabetes appear to be at similar risk for SARS-CoV-2 infection to those without diabetes, they are more likely to suffer severe consequences, including death. Diabetic ketoacidosis (DKA) is a common and potentially lethal acute complication of diabetes arising from a relative insulin deficiency, which occurs more often in those with type 1 diabetes and in the setting of moderate to severe illness. Early reports indicate that among patients with pre-existing diabetes, DKA may be a common complication of severe COVID-19 and a poor prognostic sign. Case Description This clinical perspective explores the key elements of caring for individuals with DKA during the COVID-19 pandemic through 2 cases. Topics addressed include diagnosis, triage, and the fundamental principles of treatment with a focus on the importance of characterizing DKA severity and medical complexity to determine the best approach. Conclusions As discussed, some tenets of DKA management may require flexibility in the setting of COVID-19 due to important public health goals, such as preventing transmission to highest risk individuals, reducing healthcare worker exposure to infected patients, and preserving personal protective equipment. Evidence for alternative treatment strategies is explored, with special attention placed on treatment options that may be more relevant during the pandemic, including use of subcutaneous insulin therapy. Finally, DKA is often a preventable condition. We include evidence-based strategies and guidance designed to empower clinicians and patients to avoid this serious complication when possible.Keywords
This publication has 53 references indexed in Scilit:
- Reduced Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Young Children Participating in Longitudinal Follow-UpDiabetes Care, 2011
- Managing diabetic ketoacidosis in non-intensive care unit setting: Role of insulin analogsIndian Journal of Pharmacology, 2011
- Hyperglycemic Crises in Adult Patients With DiabetesDiabetes Care, 2009
- American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic ControlDiabetes Care, 2009
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetesActa Diabetologica, 2009
- Ketosis-Prone Type 2 DiabetesDiabetes Care, 2006
- Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patientsInternational Journal of Clinical Practice, 2006
- Hepatitis C Virus Infection and Human Pancreatic β-Cell DysfunctionDiabetes Care, 2005
- Glucose ToxicityDiabetes Care, 1990
- Euglycaemic Diabetic KetoacidosisBMJ, 1973